nodes	percent_of_prediction	percent_of_DWPC	metapath
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.00316	0.00316	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00314	0.00314	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00307	0.00307	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00303	0.00303	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00302	0.00302	CbGpPWpGaD
Methantheline—CHRM1—G alpha (q) signalling events—GNRH1—polycystic ovary syndrome	0.00297	0.00297	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00296	0.00296	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00296	0.00296	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.00296	0.00296	CbGpPWpGaD
Methantheline—HRH2—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.00295	0.00295	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00294	0.00294	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00288	0.00288	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00287	0.00287	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1A—polycystic ovary syndrome	0.00286	0.00286	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00281	0.00281	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00279	0.00279	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00279	0.00279	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00279	0.00279	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00274	0.00274	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00272	0.00272	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.0027	0.0027	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—polycystic ovary syndrome	0.00266	0.00266	CbGpPWpGaD
Methantheline—CHRM1—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.00266	0.00266	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00263	0.00263	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00261	0.00261	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.00256	0.00256	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00253	0.00253	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00253	0.00253	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00253	0.00253	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00247	0.00247	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00246	0.00246	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00241	0.00241	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00241	0.00241	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00238	0.00238	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00237	0.00237	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00231	0.00231	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.0023	0.0023	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00226	0.00226	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00225	0.00225	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.00224	0.00224	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00224	0.00224	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00224	0.00224	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00219	0.00219	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00213	0.00213	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00212	0.00212	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.0021	0.0021	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00207	0.00207	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00205	0.00205	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00204	0.00204	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—TOP2A—polycystic ovary syndrome	0.00204	0.00204	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00204	0.00204	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00204	0.00204	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00201	0.00201	CbGpPWpGaD
Methantheline—CHRM1—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.00201	0.00201	CbGpPWpGaD
Methantheline—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.00199	0.00199	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00197	0.00197	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.00189	0.00189	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00187	0.00187	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00185	0.00185	CbGpPWpGaD
Methantheline—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.00185	0.00185	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.00183	0.00183	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.0018	0.0018	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.0018	0.0018	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.00179	0.00179	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NPB—polycystic ovary syndrome	0.00179	0.00179	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—TH—polycystic ovary syndrome	0.00178	0.00178	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00178	0.00178	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00176	0.00176	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00174	0.00174	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00172	0.00172	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.0017	0.0017	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.00167	0.00167	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00166	0.00166	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00163	0.00163	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00163	0.00163	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00162	0.00162	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00161	0.00161	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00161	0.00161	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00159	0.00159	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00159	0.00159	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00158	0.00158	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00155	0.00155	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00153	0.00153	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00151	0.00151	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.0015	0.0015	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.0015	0.0015	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.0015	0.0015	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00148	0.00148	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00147	0.00147	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00144	0.00144	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00144	0.00144	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00144	0.00144	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00144	0.00144	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00141	0.00141	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.0014	0.0014	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.00139	0.00139	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00137	0.00137	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00136	0.00136	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00136	0.00136	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00136	0.00136	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00134	0.00134	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00133	0.00133	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00132	0.00132	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00129	0.00129	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00128	0.00128	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00127	0.00127	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00124	0.00124	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00124	0.00124	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00124	0.00124	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.0012	0.0012	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.0012	0.0012	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00117	0.00117	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00116	0.00116	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.00114	0.00114	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00112	0.00112	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.0011	0.0011	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.0011	0.0011	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00109	0.00109	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00109	0.00109	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00107	0.00107	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00106	0.00106	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00103	0.00103	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00101	0.00101	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.001	0.001	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.001	0.001	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000996	0.000996	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000993	0.000993	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000993	0.000993	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—FST—polycystic ovary syndrome	0.000976	0.000976	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00097	0.00097	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000964	0.000964	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000953	0.000953	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000931	0.000931	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000911	0.000911	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000904	0.000904	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000902	0.000902	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.0009	0.0009	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000894	0.000894	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000893	0.000893	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000881	0.000881	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000877	0.000877	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000875	0.000875	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000866	0.000866	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000852	0.000852	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000847	0.000847	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000838	0.000838	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000837	0.000837	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00083	0.00083	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000827	0.000827	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000817	0.000817	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000812	0.000812	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000796	0.000796	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000791	0.000791	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000787	0.000787	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000777	0.000777	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000775	0.000775	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000774	0.000774	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000769	0.000769	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000764	0.000764	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000737	0.000737	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000731	0.000731	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00073	0.00073	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00073	0.00073	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000703	0.000703	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000694	0.000694	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000687	0.000687	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000683	0.000683	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000683	0.000683	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000677	0.000677	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000663	0.000663	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000645	0.000645	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000629	0.000629	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000629	0.000629	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000628	0.000628	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000606	0.000606	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.0006	0.0006	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000587	0.000587	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000585	0.000585	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000582	0.000582	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000572	0.000572	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000554	0.000554	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00055	0.00055	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000549	0.000549	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000534	0.000534	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000529	0.000529	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000523	0.000523	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000521	0.000521	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000519	0.000519	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000502	0.000502	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000489	0.000489	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000483	0.000483	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000476	0.000476	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000473	0.000473	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00047	0.00047	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000465	0.000465	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00046	0.00046	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000454	0.000454	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000451	0.000451	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00044	0.00044	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000439	0.000439	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000435	0.000435	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00043	0.00043	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000425	0.000425	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000415	0.000415	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000408	0.000408	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000405	0.000405	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000403	0.000403	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000399	0.000399	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000387	0.000387	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000378	0.000378	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000378	0.000378	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000373	0.000373	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000356	0.000356	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000339	0.000339	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000338	0.000338	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000333	0.000333	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.00033	0.00033	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—POMC—polycystic ovary syndrome	0.000325	0.000325	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—INS—polycystic ovary syndrome	0.000323	0.000323	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000313	0.000313	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000312	0.000312	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000307	0.000307	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000307	0.000307	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000297	0.000297	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000296	0.000296	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000293	0.000293	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000285	0.000285	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000284	0.000284	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00027	0.00027	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000268	0.000268	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000268	0.000268	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000258	0.000258	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000254	0.000254	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000239	0.000239	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000236	0.000236	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000224	0.000224	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00022	0.00022	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000204	0.000204	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000189	0.000189	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000185	0.000185	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000165	0.000165	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000159	0.000159	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	0.000158	0.000158	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000153	0.000153	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000152	0.000152	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000145	0.000145	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IL6—polycystic ovary syndrome	0.000141	0.000141	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000117	0.000117	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.96e-05	9.96e-05	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	6.89e-05	6.89e-05	CbGpPWpGaD
